Current approaches to pharmacotherapy for smoking cessation
Karen Suchanek Hudmon1, Robin L Corelli, Alexander V Prokhorov
1Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, Purdue University, Indianapolis, IN, USA. khudmon@purdue.edu
Therapeutic Advances in Respiratory Disease
|January 9, 2010
Summary
Smoking cessation is crucial for preventing disease and death. Pharmacotherapy combined with behavioral counseling effectively aids patients in quitting smoking, especially for those with respiratory conditions.
Area of Science:
- Pulmonology
- Public Health
- Pharmacology
Background:
- Smoking is the leading preventable cause of death and disease in the U.S.
- It is linked to numerous negative health outcomes, particularly respiratory diseases.
- Effective interventions are vital for public health initiatives.
Purpose of the Study:
- To review interventions for smoking cessation.
- To detail first-line pharmacological agents and combination therapies.
- To support respiratory therapists in patient care.
Main Methods:
- Overview of comprehensive (5 A's) and brief (Ask, Advise, Refer) behavioral interventions.
- Detailed review of seven first-line smoking cessation pharmacotherapy agents.
- Discussion of combination therapy regimens.
Main Results:
- Pharmacotherapy is recommended for most patients attempting to quit smoking.
- Behavioral counseling significantly enhances medication effectiveness.
- Specific populations may require tailored approaches due to limited evidence.
Conclusions:
- Integrated behavioral and pharmacological strategies are key to successful smoking cessation.
- Respiratory therapists can utilize this information to address smoking as a primary risk factor for pulmonary disease.
- Evidence-based cessation support improves patient outcomes.
Related Concept Videos
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:17Drug Dependence
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...